Alessia Alunno1, Francesco Carubbi2, Onelia Bistoni3, Sara Caterbi4, Elena Bartoloni5, Barbara Bigerna6, Roberta Pacini7, Daniela Beghelli8, Paola Cipriani9, Roberto Giacomelli10, Roberto Gerli11. 1. Rheumatology Unit, Department of Medicine, University of Perugia, Via Enrico Dal Pozzo, s.n.c., Perugia I-06126, Italy. Electronic address: alessia.alunno@libero.it. 2. Rheumatology Unit, Clinical Science and Biotechnology Department, University of L'Aquila, Via dell'Ospedale, s.n.c., L'Aquila I-67100, Italy. Electronic address: francescocarubbi@libero.it. 3. Rheumatology Unit, Department of Medicine, University of Perugia, Via Enrico Dal Pozzo, s.n.c., Perugia I-06126, Italy. Electronic address: o.bistoni@libero.it. 4. Rheumatology Unit, Department of Medicine, University of Perugia, Via Enrico Dal Pozzo, s.n.c., Perugia I-06126, Italy. Electronic address: s.cater@alice.it. 5. Rheumatology Unit, Department of Medicine, University of Perugia, Via Enrico Dal Pozzo, s.n.c., Perugia I-06126, Italy. Electronic address: elena.bartolonibocci@unipg.it. 6. Institute of Hematology, University of Perugia, S. Andrea delle Fratte, Perugia I-06132, Italy. Electronic address: bigernab@yahoo.it. 7. Institute of Hematology, University of Perugia, S. Andrea delle Fratte, Perugia I-06132, Italy. Electronic address: robyriky@libero.it. 8. School of Environmental Sciences, University of Camerino, Via Gentile III da Varano, Macerata I-62032, Italy. Electronic address: daniela.beghelli@unicam.it. 9. Rheumatology Unit, Clinical Science and Biotechnology Department, University of L'Aquila, Via dell'Ospedale, s.n.c., L'Aquila I-67100, Italy. Electronic address: paola.cipriani@cc.univaq.it. 10. Rheumatology Unit, Clinical Science and Biotechnology Department, University of L'Aquila, Via dell'Ospedale, s.n.c., L'Aquila I-67100, Italy. Electronic address: roberto.giacomelli@cc.univaq.it. 11. Rheumatology Unit, Department of Medicine, University of Perugia, Via Enrico Dal Pozzo, s.n.c., Perugia I-06126, Italy. Electronic address: roberto.gerli@unipg.it.
Abstract
OBJECTIVES: Growing evidence suggests that IL-17-producing T cells, lacking both CD4 and CD8 molecules and defined as double negative (DN) cells, play a pivotal role in the pathogenesis of a number of systemic autoimmune disorders. We recently demonstrated that this T-cell subset is expanded in the peripheral blood (PB) of patients with primary Sjögren's syndrome (pSS), produces IL-17 and accumulates in minor salivary glands (MSGs). We aimed to investigate glandular and PB DN T cells in early pSS in order to verify a possible correlation with MSGs histological patterns and clinical parameters. METHODS: Paired samples of PB mononuclear cells and MSGs from pSS patients were evaluated at the diagnosis by flow cytometry and immunofluorescence staining respectively. Histological analysis to identify histological scores, B/T cell segregation and the presence of germinal center (GC)-like structures was also performed. RESULTS: In early stages of pSS, circulating DN T cells appear to be not yet expanded and inversely correlated with circulating CD4(+)Th17 cells. The number of infiltrating DN T cells were associated with extent of glandular involvement, presence of GC-like structures and dryness symptoms and were inversely correlated with circulating DN T cells. CONCLUSIONS: Our findings suggest that DN T cells are actively involved in the pathogenic mechanisms leading to glandular dysfunction and damage in pSS and may play a role in ectopic lymphoneogenesis development occurring during the disease.
OBJECTIVES: Growing evidence suggests that IL-17-producing T cells, lacking both CD4 and CD8 molecules and defined as double negative (DN) cells, play a pivotal role in the pathogenesis of a number of systemic autoimmune disorders. We recently demonstrated that this T-cell subset is expanded in the peripheral blood (PB) of patients with primary Sjögren's syndrome (pSS), produces IL-17 and accumulates in minor salivary glands (MSGs). We aimed to investigate glandular and PB DN T cells in early pSS in order to verify a possible correlation with MSGs histological patterns and clinical parameters. METHODS: Paired samples of PB mononuclear cells and MSGs from pSSpatients were evaluated at the diagnosis by flow cytometry and immunofluorescence staining respectively. Histological analysis to identify histological scores, B/T cell segregation and the presence of germinal center (GC)-like structures was also performed. RESULTS: In early stages of pSS, circulating DN T cells appear to be not yet expanded and inversely correlated with circulating CD4(+)Th17 cells. The number of infiltrating DN T cells were associated with extent of glandular involvement, presence of GC-like structures and dryness symptoms and were inversely correlated with circulating DN T cells. CONCLUSIONS: Our findings suggest that DN T cells are actively involved in the pathogenic mechanisms leading to glandular dysfunction and damage in pSS and may play a role in ectopic lymphoneogenesis development occurring during the disease.
Authors: Guillermo Carvajal Alegria; Pierre Gazeau; Sophie Hillion; Claire I Daïen; Divi Y K Cornec Journal: Clin Rev Allergy Immunol Date: 2017-10 Impact factor: 8.667
Authors: Noé Rodríguez-Rodríguez; Sokratis A Apostolidis; Pablo Penaloza-MacMaster; José Manuel Martín Villa; Dan H Barouch; George C Tsokos; José C Crispín Journal: J Immunol Date: 2015-03-30 Impact factor: 5.422
Authors: A Wiener; A Schippers; N Wagner; F Tacke; T Ostendorf; N Honke; K Tenbrock; K Ohl Journal: Clin Exp Immunol Date: 2016-04-18 Impact factor: 4.330
Authors: A Alunno; F Carubbi; O Bistoni; S Caterbi; E Bartoloni; P Di Benedetto; P Cipriani; R Giacomelli; R Gerli Journal: Clin Exp Immunol Date: 2016-03-03 Impact factor: 4.330